APT vs IBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 16, 2026

APT

34.0
AI Score
VS
IBIO Wins

IBIO

44.7
AI Score

Investment Advisor Scores

APT

34score
Recommendation
AVOID NEW MONEY

IBIO

45score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric APT IBIO Winner
Forward P/E 5.9844 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 12.0% -100.0% APT
Earnings Growth 52.0% 0.0% APT
Tradestie Score 34.0/100 44.7/100 IBIO
Profit Margin 6.8% 0.0% APT
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD IBIO

Relative Price Performance (Last 90 Days)

APT 1M: +11.6% · 3M: +13.2% IBIO 1M: -40.2% · 3M: -50.5%

Current Technical Phase

APT

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.5% over 20 days), RSI 52

RSI (14): 52.1 · Price: $5.56

IBIO

Markdown
Sell / avoid

Price below a falling SMA50 (slope -14.0%), weak momentum, RSI 25

RSI (14): 24.9 · Price: $0.72

Fundamentals Snapshot

Metric APT IBIO
Market Cap — —
Forward P/E 6.0 -2.3
Trailing P/E 14.2 —
Revenue (TTM) — —
Revenue Growth 0.1% -1.0%
Gross Margin 0.4% 1.0%
Operating Margin 0.1% -301.4%
EPS 0.39 -0.32
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IBIO is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.